Health Sciences Authority
Respiree is also preparing to file for regulatory approval for its AI tool in the United States and across Australia, New Zealand, and Asia.
Also, Singapore has approved a lung cancer imaging AI platform.
After pilots in Singapore and Australia, AIGP Health targets Indonesia and Malaysia for expansion.
The company develops AI tools to analyse chest x-rays and breast mammography.